Emicizumab-kxwh Subcutaneous and Methylphen Tablets
Determining the interaction of Emicizumab-kxwh Subcutaneous and Methylphen Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: benzoic acid / hyoscyamine / methenamine / methylene blue / phenyl salicylate
Brand name: Hyophen, Prosed/DS, Urophen MB
Synonyms: Methenamine, Phenyl Salicylate, Methylene Blue, Benzoic Acid, Hyoscyamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Methylphenidate
- Emicizumab-kxwh Subcutaneous-Methylphenidate CD Capsules
- Emicizumab-kxwh Subcutaneous-Methylphenidate Chewable Tablets
- Emicizumab-kxwh Subcutaneous-Methylphenidate Controlled-Release Tablets
- Emicizumab-kxwh Subcutaneous-Methylphenidate ER Capsules
- Emicizumab-kxwh Subcutaneous-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Methylphen Tablets-Emla
- Methylphen Tablets-Emla Topical
- Methylphen Tablets-Emo-Cort Scalp Solution Topical application
- Methylphen Tablets-Emo-Cort Topical application
- Methylphen Tablets-Emoquette
- Methylphen Tablets-Empagliflozin